CLONZIT-2 MD

CLONZIT-2 MD is a pharmaceutical formulation containing Clonazepam 2 mg in a mouth-dissolving tablet dosage form. Clonazepam belongs to the benzodiazepine class of medicines and is a centrally acting pharmaceutical compound. The product is presented as a 2 mg strength under the CLONZIT-2 MD brand.

The mouth-dissolving tablet formulation is a specific oral dosage form designed to disintegrate in the mouth. This distinguishes it from conventional tablets intended to be swallowed whole. The product's strength, active ingredient and dosage form are key details for accurate pharmaceutical identification, catalogue management and procurement.

CLONZIT-2 MD is supplied in a blister-pack presentation containing 10 strips of 10 tablets, giving a total pack quantity of 100 tablets. Its product information can be organised within the psychiatric products section of a pharmaceutical catalogue for professional reference by authorised healthcare providers and institutional procurement teams.